Drug Search Results
More Filters [+]

Phenazone

Alternative Names: phenazone
Latest Update: None
Latest Update Note: None

Product Description

Mechanisms of Action: COX Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Algeria | Australia | Bangladesh | Bulgaria | Canada | Chile | Egypt | Estonia | France | Hong Kong | Hungary | India | Ireland | Jordan | Lithuania | Malta | Mexico | Morocco | New Zealand | Norway | Pakistan | Peru | Philippines | Portugal | Russia | Saudi Arabia | Singapore | Spain | Sweden | Tunisia | Turkey | Ukraine | United Arab Emirates | United Kingdom | Venezuela | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Phenazone

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events

Date

Type

Title